Bittium Exhibits its High-Tech Medical Technology Products and R&D Services for Medical and Healthcare Technology

BittiumBittium exhibits its innovative products and solutions for cardiology and neurophysiology as well as R&D services for the development of medical and healthcare technology at the MEDICA 2021 event. It is the world's biggest trade fair for the medical market, and it will be organized in Düsseldorf, Germany on November 15-18, 2021.

Bittium's team of Medical Technologies experts are showcasing advanced high-tech solutions for monitoring of heart, brain and sleeping disorders. The solutions enable early detection of abnormalities in body's electrical activities and sleep-related breathing disorders, thus speeding up the diagnosis and further treatment of a patient. All Bittium's cardiology, neurophysiology and sleeping disorder measurement solutions are integrated with the cloud-based back-end systems that enable the analysis of data regardless of location.

Bittium's team of R&D services experts are showcasing services for medical and healthcare technology that enable for example the development of innovative wireless devices that use the latest technologies and can be used in or outside the hospital. Customers using the R&D services benefit from Bittium’s strong expertise and experience in all stages of product development, including versatile know-how of both hardware and software, as well as specialized expertise in wireless connectivity and information security. The high quality of the product development projects is based on processes carried out according to the ISO 13485 certificate.

The Medical Technologies team is located at stand 9/C15 exhibiting the following products and solutions:

Products and solutions for cardiology:

  • Bittium Faros™ ECG measuring and monitoring device
  • Bittium Cardiac Navigator™ analysis software for ECG measurement data
  • Bittium OmegaSnap™ a family of disposable ECG patch electrodes
  • Bittium HolterPlus™ web-based remote cardiac monitoring solution

Products and solutions for neurophysiology:

  • Bittium BrainStatus™ a compact EEG measuring and monitoring system
  • Bittium BrainStatus™ with Cerenion C-Trend for measuring the brain function of intensive care patients
  • Bittium NeurOne™ the most accurate EEG measuring device
  • Bittium Respiro™ a modern sleep apnea screening device and analysis service solution
  • Bittium Respiro Analyst™ analysis software for sleep apnea measurement data

Visit https://www.bittium.com/medical for more information on the offering.

The R&D services team is located at stand 12/D21 and exhibiting the following solutions:

  • Wireless solutions - One of Bittium’s core competencies is mastering different radio and antenna technologies and their application to different solutions using wireless connectivity. Bittium's in-house RF and antenna test laboratories support the development work and enable comprehensive project deliveries to the customers.
  • Innovative, power-optimized devices - Bittium specializes in the development of small, power-optimized devices that include different sensors. The device development expertise is complemented with strong know-how of embedded software and the combination enables development of different types of systems for demanding environments.
  • Standards-based services - The high quality of Bittium’s R&D services is based on processes carried out according to the ISO 13485 certificate, and Bittium’s in-house test laboratories are utilized in the verification and validation of the products.

Visit https://www.bittium.com/rd-services/healthcare-medical for more information on the offering.

About Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 years’ legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...